Good post on Reddit from MGK
https://www.reddit.com/r/Livimmune/comments/1..._the_road/
Where The Rubber Meets The Road
Kosher Cool here at CytoDyn.
Lalezari has control in his hands and we the shareholders are satisfied with it.
Ever since COVID, CytoDyn really started to become much more recognized. Don't get me wrong. I know that CytoDyn is a tiny company right now, I realize that. But it is a tiny company known by a shit-ton of shareholders, especially ever since COVID.
The goal of course, is to grow this company, to become more like some of the other better known, more well-known Pharmaceutical companies. The goal being to have CytoDyn assimilate with its current competitors and become another Bio-Tech Pharma. To minimize the number of enemies it has in this space and to make friends wherever possible. Yes, that is the goal, right?
So Lalezari has free reign to do as he pleases to achieve that goal. But because of what he had to deal with; because of what he took over, a battered down company which was nearly completely disheveled, on the brink of ruin and almost entirely broken apart, many of his would-be shareholders, had exited a long while prior to his beginning. Yes, many shareholders were still present, but there also exist a good many more in the shadows waiting for the sign to return. In addition, he virtually had zero institutional investors.
Originally, the majority of shareholders were in the company for HIV. There were many shareholders in CYDY for HIV. When Cyrus Arman was forced to discontinue the HIV-MDR BLA, many shareholders were completely apalled and let down and subsequently got out of the company. Many heavy-handed shareholders let their shares go. In addition, and prior to that, when Gilead was chosen over CytoDyn for mTNBC, many shareholders holding out for leronlimab for mTNBC Break Through Designation exited. And I'm talking millions of shares were sold back to short traders. But they continue to watch and wait until they are again convinced of a definitive success.
They remain in the shadows. COVID came, and a shot was made, and the shot missed its mark. That was the only shot they were given, and they blew it. In addition, a Clinical Hold which lasted 2.5 years was imposed. The shareholders who entered because of COVID left, but they too, remain vigilant. Their eyes are glued wide open, watching.
These shareholders of course are in other stocks now, but given the current state of turmoil, there may be a day on the horizon when they might decide to extricate themselves out of said stocks. If it becomes quite mandatory to exit, as in, flee for one's life, otherwise, both you and your home are scorched alive in the forest fire. That time when it becomes mandatory to flee those stocks could be on the horizon. These shareholders, who have been looking for an excuse to exit, to ensure they remain out of the way of danger and to return back to something that stands for what they believe in, that is run by a man with conviction, that has goals and an almost assured path to victory.
What I suspect could happen, is that they appreciate that the fire is too close for comfort, that it becomes mandatory for them, if they wish to remain alive to see another day, that they leave. There cannot be a person reading this today, that can deny the trouble happening today in America, and even the whole world. Coming apart at the seams and if you want to pooh-pooh this, go ahead, at your own peril. I'm telling you the way I'm seeing it.
So, it might not be a mandatory evacuation right now, but you can tell, the fire is getting close, don't you think? Things are heating up. Heating up to what? To something like a volcanic eruption? Don't take my word for it Folks. You make up your own mind.
Lalezari has his hands on the reins. As a few have said here, CytoDyn has multiple shots on goal. But as you know, CytoDyn has a few enemies who wish to maintain the pressure over CytoDyn in order to interfere with them reaching their goals. All of the goals which Dr. Lalezari has mentioned to CYDY shareholders, could have even angered those same enemies at a greater level. So, we have a confident leader, but, behind the scenes, we may be unaware of the danger which lurks ahead. So, I'm just saying, there might be smoke and where there is smoke, there is fire.
We find ourselves in GlioBlastoma Multiforme, Metastatic Colo-Rectal Cancer, Inflammation / Immune Activation, MASH, Alzheimer's Disease, HIV-Cure via AAV and via LATCH, HIV-Prep, Long-Hauler's and more. With so much to concern ourselves with, do you think we have any surrounding enemies who have the same goals? As Lalezari establishes a footing into each one of these goals/indications, that long lost shareholder base returns back into the fold and strengthens the CYDY stronghold. As CytoDyn succeeds and builds upon each one of these indications, the numbers of shareholders who have now become permanent holders of CYDY, begin to turn CytoDyn into more of its intended role, that of a Bio-Tech Pharma. This becomes more and more realistic as leronlimab wins goal after goal, to the point that the enemies realize that this movement has become unstoppable.
CytoDyn should not be as popular as it is. Why not? Because it is a one trick wonder that has failed in every attempt at success thus far. But it is not a one trick wonder. It is a one drug company, but not a one disease company. It failed because it was sabotaged, not because of any inherent flaw in the drug itself. Yes, the company was riddled with flaws, but not the drug. Seriously, the company should be over and done with, kaput already, but instead, it remains on its feet. Why? Just look at the number of peer-reviewed journal articles discussing the multitude of benefits of CCR5 blockade, in a myriad of massive disease indications. A tremendous number of shareholders entered the stock around 2020, the time of COVID and because of what the drug is capable of doing and because of the circumstances, sufficient quantities of shareholders have chosen to stick it out because they have believed in its successful outcome. In addition, it is not only them and their quantities. They have also witnessed many miraculous things which have taken place, which cannot be fully explained. Some which should not have occurred but only confirm to the witnesses, that something else here is at play. Do I think more miracles are on the way? Absolutely.
When? Dr. Lalezari has indicated that the results of the MASH murine study should be forthcoming in the fall of 2024. I've said that as late as Thanksgiving, but certainly, I believe, something astonishing occurs before that, even early October, but who knows. The company is going to break out and soon. We got our wings now, as we don't have to pay Samsung until we ourselves get paid. In addition, about $14 million in debt has been erased. We shall be hearing about the results of these studies in the fall. We shall be underway in the mCRC trial. We shall have papers published about the true results in some of the trials we did in the past that discuss mTNBC, COVID and HIV-MDR. The fall, early winter seems to me a moment in time that promises a turning point in CytoDyn's trajectory.
By the end of the year, I suspect, the majority of those shareholders who had exited CYDY in the past or who yet remain on the fence waiting to see what will happen, shall have, by then, re-entered the fold. All the indications which these caving shareholders folded on are the same indications which they return on, this time though, under Lalezari who already knows where this is going on every front.
A turning point is in the making as we speak. We are approaching that time when in the right sequence of events, decisions are made which reinforce convictions that solidly plant shareholders back here in. It appears that CytoDyn has a bunch of work to do, yet the means to accomplish even one of these goals is quite difficult. Just wait on the news Folks and see what happens as a result. The news of what happens with these studies and trials. Wait on the peer reviewed papers. Wait on what Madrigal does when they see the results of the murine study. I suspect, things might get pretty hot around that time and there may be need for some folks to escape some fiery flames. The heat is rising and that time approaches and it is not that far away. 3-4 months only.
I hope this addressed some of the stress, strain and concerns. It is happening Folks and it shall unfold accordingly, but there is a lot of waiting involved, but thankfully, it has been an interesting wait.
Have a nice Sunday and have a nice week.
https://www.reddit.com/r/Livimmune/comments/1..._the_road/
Where The Rubber Meets The Road
Kosher Cool here at CytoDyn.
Lalezari has control in his hands and we the shareholders are satisfied with it.
Ever since COVID, CytoDyn really started to become much more recognized. Don't get me wrong. I know that CytoDyn is a tiny company right now, I realize that. But it is a tiny company known by a shit-ton of shareholders, especially ever since COVID.
The goal of course, is to grow this company, to become more like some of the other better known, more well-known Pharmaceutical companies. The goal being to have CytoDyn assimilate with its current competitors and become another Bio-Tech Pharma. To minimize the number of enemies it has in this space and to make friends wherever possible. Yes, that is the goal, right?
So Lalezari has free reign to do as he pleases to achieve that goal. But because of what he had to deal with; because of what he took over, a battered down company which was nearly completely disheveled, on the brink of ruin and almost entirely broken apart, many of his would-be shareholders, had exited a long while prior to his beginning. Yes, many shareholders were still present, but there also exist a good many more in the shadows waiting for the sign to return. In addition, he virtually had zero institutional investors.
Originally, the majority of shareholders were in the company for HIV. There were many shareholders in CYDY for HIV. When Cyrus Arman was forced to discontinue the HIV-MDR BLA, many shareholders were completely apalled and let down and subsequently got out of the company. Many heavy-handed shareholders let their shares go. In addition, and prior to that, when Gilead was chosen over CytoDyn for mTNBC, many shareholders holding out for leronlimab for mTNBC Break Through Designation exited. And I'm talking millions of shares were sold back to short traders. But they continue to watch and wait until they are again convinced of a definitive success.
They remain in the shadows. COVID came, and a shot was made, and the shot missed its mark. That was the only shot they were given, and they blew it. In addition, a Clinical Hold which lasted 2.5 years was imposed. The shareholders who entered because of COVID left, but they too, remain vigilant. Their eyes are glued wide open, watching.
These shareholders of course are in other stocks now, but given the current state of turmoil, there may be a day on the horizon when they might decide to extricate themselves out of said stocks. If it becomes quite mandatory to exit, as in, flee for one's life, otherwise, both you and your home are scorched alive in the forest fire. That time when it becomes mandatory to flee those stocks could be on the horizon. These shareholders, who have been looking for an excuse to exit, to ensure they remain out of the way of danger and to return back to something that stands for what they believe in, that is run by a man with conviction, that has goals and an almost assured path to victory.
What I suspect could happen, is that they appreciate that the fire is too close for comfort, that it becomes mandatory for them, if they wish to remain alive to see another day, that they leave. There cannot be a person reading this today, that can deny the trouble happening today in America, and even the whole world. Coming apart at the seams and if you want to pooh-pooh this, go ahead, at your own peril. I'm telling you the way I'm seeing it.
So, it might not be a mandatory evacuation right now, but you can tell, the fire is getting close, don't you think? Things are heating up. Heating up to what? To something like a volcanic eruption? Don't take my word for it Folks. You make up your own mind.
Lalezari has his hands on the reins. As a few have said here, CytoDyn has multiple shots on goal. But as you know, CytoDyn has a few enemies who wish to maintain the pressure over CytoDyn in order to interfere with them reaching their goals. All of the goals which Dr. Lalezari has mentioned to CYDY shareholders, could have even angered those same enemies at a greater level. So, we have a confident leader, but, behind the scenes, we may be unaware of the danger which lurks ahead. So, I'm just saying, there might be smoke and where there is smoke, there is fire.
We find ourselves in GlioBlastoma Multiforme, Metastatic Colo-Rectal Cancer, Inflammation / Immune Activation, MASH, Alzheimer's Disease, HIV-Cure via AAV and via LATCH, HIV-Prep, Long-Hauler's and more. With so much to concern ourselves with, do you think we have any surrounding enemies who have the same goals? As Lalezari establishes a footing into each one of these goals/indications, that long lost shareholder base returns back into the fold and strengthens the CYDY stronghold. As CytoDyn succeeds and builds upon each one of these indications, the numbers of shareholders who have now become permanent holders of CYDY, begin to turn CytoDyn into more of its intended role, that of a Bio-Tech Pharma. This becomes more and more realistic as leronlimab wins goal after goal, to the point that the enemies realize that this movement has become unstoppable.
CytoDyn should not be as popular as it is. Why not? Because it is a one trick wonder that has failed in every attempt at success thus far. But it is not a one trick wonder. It is a one drug company, but not a one disease company. It failed because it was sabotaged, not because of any inherent flaw in the drug itself. Yes, the company was riddled with flaws, but not the drug. Seriously, the company should be over and done with, kaput already, but instead, it remains on its feet. Why? Just look at the number of peer-reviewed journal articles discussing the multitude of benefits of CCR5 blockade, in a myriad of massive disease indications. A tremendous number of shareholders entered the stock around 2020, the time of COVID and because of what the drug is capable of doing and because of the circumstances, sufficient quantities of shareholders have chosen to stick it out because they have believed in its successful outcome. In addition, it is not only them and their quantities. They have also witnessed many miraculous things which have taken place, which cannot be fully explained. Some which should not have occurred but only confirm to the witnesses, that something else here is at play. Do I think more miracles are on the way? Absolutely.
When? Dr. Lalezari has indicated that the results of the MASH murine study should be forthcoming in the fall of 2024. I've said that as late as Thanksgiving, but certainly, I believe, something astonishing occurs before that, even early October, but who knows. The company is going to break out and soon. We got our wings now, as we don't have to pay Samsung until we ourselves get paid. In addition, about $14 million in debt has been erased. We shall be hearing about the results of these studies in the fall. We shall be underway in the mCRC trial. We shall have papers published about the true results in some of the trials we did in the past that discuss mTNBC, COVID and HIV-MDR. The fall, early winter seems to me a moment in time that promises a turning point in CytoDyn's trajectory.
By the end of the year, I suspect, the majority of those shareholders who had exited CYDY in the past or who yet remain on the fence waiting to see what will happen, shall have, by then, re-entered the fold. All the indications which these caving shareholders folded on are the same indications which they return on, this time though, under Lalezari who already knows where this is going on every front.
A turning point is in the making as we speak. We are approaching that time when in the right sequence of events, decisions are made which reinforce convictions that solidly plant shareholders back here in. It appears that CytoDyn has a bunch of work to do, yet the means to accomplish even one of these goals is quite difficult. Just wait on the news Folks and see what happens as a result. The news of what happens with these studies and trials. Wait on the peer reviewed papers. Wait on what Madrigal does when they see the results of the murine study. I suspect, things might get pretty hot around that time and there may be need for some folks to escape some fiery flames. The heat is rising and that time approaches and it is not that far away. 3-4 months only.
I hope this addressed some of the stress, strain and concerns. It is happening Folks and it shall unfold accordingly, but there is a lot of waiting involved, but thankfully, it has been an interesting wait.
Have a nice Sunday and have a nice week.
5
